Drug Shortage Report for METHOTREXATE INJECTION USP

Last updated on 2024-11-08

Report ID 239733
Drug Identification Number 02182955
Brand name METHOTREXATE INJECTION USP
Common or Proper name METHOTREXATE 50MG/2ML
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) METHOTREXATE
Strength(s) 25MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRATHECAL INTRAMUSCULAR INTRA-ARTERIAL INTRACEREBROVENTRICULAR INTRACEREBROVENTRICULAR INTRAVENOUS INTRATHECAL INTRAMUSCULAR INTRA-ARTERIAL
Packaging size 2ML VIAL
ATC code L01BA
ATC description ANTIMETABOLITES
Reason for shortage Demand increase for the drug.
Anticipated start date 2024-10-27
Actual start date
Estimated end date
Actual end date 2024-11-07
Shortage status Resolved
Updated date 2024-11-08
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: [email protected]

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2024-11-08 English Compare
v5 2024-11-07 French Compare
v4 2024-11-07 English Compare
v3 2024-10-28 English Compare
v2 2024-10-09 French Compare
v1 2024-10-09 English Compare

Showing 1 to 6 of 6